Republished from The Children's Prize Foundation Newsletter
Oncolinx, in conjunction with the National Cancer Institute is developing the next generation of targeted cancer therapies: antibody-drug conjugates (ADCs). Oncolinx ADCs carry a patented, immune-activating drug payload called the Azonafide directly, and exclusively, to cancer cells, and not healthy cells, thereby avoiding many of the adverse side-effects of chemotherapy.
Each year, the 43North business competition awards $5 million in cash prizes and services to some of the best and brightest entrepreneurs and startups from around the globe. Awards include a one $1 million grand prize, six $500,000 prizes and four $250,000 prizes.
43North is part of New York Governor Andrew Cuomo’s Buffalo Billion initiative, which is driving new economic opportunities...
Meet the students who will compete in Washington D.C., and find out why their inventions stand out among this year’s most inspiring entries.
In partnership with the Red Cross, The Paradigm Challenge is an annual competition that inspires youth innovation to address important social issues. The first annual Challenge sought to generate new ideas to prevent injuries and fatalities from home fires—America’s #1 disaster threat.